The Central Mine Planning IPO has recently made headlines, with expectations initially set high among investors. The anticipation surrounding this initial public offering was fueled by the company’s established history, having been incorporated in 1975, and its role in providing consultancy and support services for coal and mineral exploration.
However, the landscape shifted dramatically as the IPO bidding progressed. On the third day of bidding, the Central Mine Planning IPO was fully subscribed, achieving a subscription rate of 1.05 times. This figure, while positive, did not meet the more optimistic forecasts that had circulated prior to the launch.
Breaking down the subscription figures reveals that Qualified Institutional Buyers (QIBs) accounted for 62 percent of the subscriptions, while Retail Individual Investors contributed 20 percent. This distribution indicates a stronger interest from institutional investors compared to retail participants, which may reflect varying levels of confidence in the offering.
The IPO price band was fixed at Rs 163-172 per share, valuing the company at approximately Rs 12,280 crore at the higher end of the price range. Despite these figures, the grey market premium (GMP) has been notably subdued, with the final GMP reported at ₹0.85. This suggests that the market’s expectations for immediate gains are tepid.
According to platforms tracking grey-market activity, the shares of Central Mine Planning are commanding a flat GMP in the unofficial market. This is a stark contrast to the potential gains that investors often hope for during an IPO. The expected listing price is pegged at ₹172.85, indicating a marginal gain of 0.49% per share, which is far from the robust returns typically associated with successful IPOs.
The IPO has successfully mobilized Rs 470 crore from anchor investors, which underscores a degree of institutional confidence. However, the mixed response from retail investors and the flat GMP raises questions about the long-term viability of the stock once it lists on March 30.
As the IPO allotment is expected by March 25, the market will be closely watching how the shares perform post-listing. The contrasting dynamics between institutional and retail interest could play a significant role in shaping the stock’s trajectory.
Experts suggest that while the initial subscription figures are encouraging, the subdued GMP and the overall market sentiment may temper expectations. Investors are advised to proceed with caution, given the current indicators.
Details remain unconfirmed regarding the long-term implications of this IPO on the broader market, but the initial signs suggest a cautious approach may be warranted.
